Enterome

The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.

The companies will discover and develop microbiome-derived biomarkers, drug targets, and bioactive molecules for cancer.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.